Viewing Study NCT03176966


Ignite Creation Date: 2025-12-24 @ 4:39 PM
Ignite Modification Date: 2026-01-04 @ 3:05 AM
Study NCT ID: NCT03176966
Status: COMPLETED
Last Update Posted: 2022-10-31
First Post: 2017-06-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis
Sponsor: Vanderbilt University Medical Center
Organization:

Study Overview

Official Title: Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis
Status: COMPLETED
Status Verified Date: 2022-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigator's aim is to compare the efficacy of Ropinirole (Requip) to vitamin E in the treatment of muscle cramps in cirrhotic patients.
Detailed Description: Muscle cramps are common in liver disease, especially in patients with cirrhosis. Despite the association of muscle cramps with liver disease, there is a paucity of information regarding treatment in these patients. Many treatment options have been reported in the literature but no standard of treatment has been established.

Oral vitamin E replacement has been used successfully in the management of nocturnal muscle cramps in cirrhotic patients. Ropinirole is primarily used for treatment of restless leg syndrome. An off label trial of low dose Ropinirole in clinical practice has shown some success in providing relief of muscle cramps in patients with cirrhosis. This study will compare Ropinirole to vitamin E treatment in a prospective cross-over study.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: